Rapid respiratory disease test VMD81
for antigensadenovirusrespiratory syncytial virus

rapid respiratory disease test
rapid respiratory disease test
Add to favorites
Compare this product
 

Characteristics

Applications
for respiratory diseases
Tested parameter
for antigens
Micro-organism
SARS-COV-2, influenza A, influenza B, adenovirus, respiratory syncytial virus, RSV, Mycoplasma pneumoniae
Sample type
nasopharyngeal, laboratory
Analysis mode
chromatographic immunoassay

Description

The SARS-CoV-2 + Influenza A/B + RSV + Adenovirus + M.pneumoniae Combo Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus and M.pneumoniae antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV 2 / Influenza / RSV / Adenovirus / M.pneumoniae infection in conjunction with clinical presentation and the results of other laboratory tests. Advantages – 4in1 test for multiple virus detection – Ergonomic design for minimum risk of contamination – Easy to follow procedure – Accurate and reliable result Box Content – Swab – Extraction Buffer – Dropper – User Manual

Catalogs

No catalogs are available for this product.

See all of Vitrosens Biotechnology Ltd.‘s catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

MEDICA 2024
MEDICA 2024

11-14 Nov 2024 Düsseldorf (Germany) Hall 1 - Stand D39

  • More information

    Other Vitrosens Biotechnology Ltd. products

    Respiratory Tests

    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.